Skip to main content
RACC
NASDAQ Real Estate & Construction

RACC Flags Material Weakness and Going Concern Doubt in Q2 10-Q

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Real Estate
Sentiment info
Negative
Importance info
8
Price
$29.3
Mkt Cap
$266.587M
52W Low
$10.21
52W High
$33.5
52W Position info
187% above low
Off High info
13% below high
Rel. Volume info
2.1× avg
Market data snapshot near publication time

RACC has more than doubled off its 52-week low of $10.21 on elevated volume (2.1× avg).

Summary

RACC's Q2 10-Q discloses a material weakness in internal controls and a going concern warning, raising substantial doubt about its ability to continue as a going concern.


Key Events · Corporate Governance and Compliance · RACC

  • Material Weakness Disclosed

    A material weakness in internal control over financial reporting has been reported, specifically related to the accuracy and classification of accounts payable and accrued expenses. Management concluded that disclosure controls and procedures were not effective as of June 30, 2026.

  • Going Concern Warning

    The 10-Q states that the company lacks financial resources to sustain operations for a reasonable period, raising substantial doubt about its ability to continue as a going concern. As of June 30, 2026, cash stood at $832,812 and working capital at $905,874.

  • Remediation Plan Underway

    Management has implemented enhanced review controls over accruals and payables, detective controls for cut-off, and improved vendor trend analysis, but full remediation is not yet complete.

  • Pending Oak Hill Bio Merger

    The going concern and control issues arise while the company pursues its announced business combination with Oak Hill Bio, expected to close in the second half of 2026. The merger is backed by $100 million in committed financing.


Analysis · RACC · Real Estate & Construction

The second-quarter 10-Q from Research Alliance Corp III surfaces two critical issues: a material weakness in internal controls over accounts payable and accrued expenses, and a going concern warning. With insufficient financial resources to sustain operations for a reasonable period, the company acknowledges substantial doubt about its ability to continue. These disclosures are new and material, particularly for a SPAC that has already announced a business combination with Oak Hill Bio. The material weakness points to accounting control deficiencies that could erode confidence in financial reporting, while the going concern language underscores liquidity risk despite the pending merger.

At the time of this filing, RACC was trading at $29.30 on NASDAQ in the Real Estate & Construction sector, with a market capitalization of approximately $266.6M. The 52-week trading range was $10.21 to $33.50. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

RACC - Latest Insights

RACC
Jul 27, 2026, 8:24 AM EDT
Filing Type: 425
Importance Score:
9
Price at Filing: $12.50
Real-time Price: $29.30 info
Change: +$16.80 (+134%) info
Market Cap: $266.587M info
RACC
Jul 27, 2026, 8:18 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $11.67
Real-time Price: $29.30 info
Change: +$17.63 (+151%) info
Market Cap: $266.587M info
RACC
Jul 02, 2026, 4:01 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $11.30
Real-time Price: $29.30 info
Change: +$18.00 (+159%) info
Market Cap: $266.587M info
RACC
May 29, 2026, 5:28 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
8
Price at Filing: $10.38
Real-time Price: $29.30 info
Change: +$18.92 (+182%) info
Market Cap: $266.587M info
RACC
May 28, 2026, 5:26 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $10.40
Real-time Price: $29.30 info
Change: +$18.90 (+182%) info
Market Cap: $266.587M info